PREZISTA 150 mg, film-coated tablet 240 tablets
Active ingredients: Darunavir, Darunavir ethanolate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet240 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PREZISTA 150 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 240 comprimé(s)
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Apr 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63216342CIP73959536CIP133400939595368Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DARUNAVIRcomprimé | 150 mg · un comprimé | FT |
| ÉTHANOLATE DE DARUNAVIRcomprimé | 162,62 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.